PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
 
Proc R Soc Med. 1960 August; 53(8): 595–603.
PMCID: PMC1869421

Oral Hypoglycæmic Agents in the Treatment of Diabetes Mellitus

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • ASHWORTH MA, HAIST RE. Some effects of BZ-55 (carbutamide) on the growth of the islets of Langerhans. Can Med Assoc J. 1956 Jun 15;74(12):975–976. [PMC free article] [PubMed]
  • BLOOM A. Remission in diabetes. Br Med J. 1959 Oct 17;2(5154):731–734. [PMC free article] [PubMed]
  • BRION A, FONTAINE M. Diabètes spontanés chez le chien et sulfamidés hypoglycémiants. Therapie. 1959;14(1):68–69. [PubMed]
  • FAJANS SS, CONN JW. Tolbutamide-induced improvement in carbohydrate tolerance of young people with mild diabetes mellitus. Diabetes. 1960 Mar-Apr;9:83–88. [PubMed]
  • GEPTS W, CHRISTOPHE J, BELLENS R. Etude expérimentale d'un sulfamide hypoglycémiant. I. Modifications morphologiques, et en particulier pancréatiques, provoquées chez le rat normal et la rat diabétique par le R.P. 2 254. Ann Endocrinol (Paris) 1955;16(6):946–955. [PubMed]
  • HOUSSAY BA, MIGLIORINI RH. Renforcement de l'action de l'insuline par les sulfamides hypoglycémiants. C R Seances Soc Biol Fil. 1956;150(8-9):1620–1621. [PubMed]
  • JORES J, KRACHT J. [Effect of sulfonylurea compounds on the mitosis frequency of islet beta cells]. Acta Endocrinol (Copenh) 1959 Oct;32:243–254. [PubMed]
  • LACY PE, HARTROFT WS. Electron microscopy of the islets of Langerhans. Ann N Y Acad Sci. 1959 Sep 25;82:287–301. [PubMed]
  • JAHNKE W. Retinopathia diabetica und Insulinschäden am Auge. Hippokrates. 1959 Apr 15;30(7):279–283. [PubMed]
  • LOUBATIERES A, BOUYARD P, DE FRUTEAU LACLOS C. Analyse ou mécanisme de l'action curatrice que le para-aminobenzéne-sulfamido-isopropylthiodiazol exerce sur le diabète sucré experimental provoqué par l'alloxane. C R Hebd Seances Acad Sci. 1955 Aug 1;241(5):515–516. [PubMed]
  • LOUBATIERES A, BOUYARD P, FRUTEAU DE LACLOS C, SASSINE A, ALRIC R. Renforcement et prolongation des effets de l'insuline par les sulfamidés hypoglycémiants et antidiabétiques. C R Seances Soc Biol Fil. 1956;150(8-9):1601–1603. [PubMed]
  • LOUBATIERES A, FRUTEAU DE LACLOS C. Preuves histologiques de l'action beta-cytotrope pancréatique des arylsulfonamides hypoglycémiants. C R Seances Soc Biol Fil. 1958;152(12):1760–1763. [PubMed]
  • LOUBATIERES A, FRUTEAU DE LACLOS C, MARIANI MM, SASSINE A. [On the importance of maintenance of the exocrine and endocrine functions of the pancreas for the proper tolerance of certain sulfonamides and the manifestation of their hypoglycemic and antidiabetic action]. C R Seances Soc Biol Fil. 1960;154:173–175. [PubMed]
  • LOUBATIERES A, SASSINE A, MARIANI MM, FRUTEAU DE LACLOS C. [Effects of the administration of sulfonamide by way of the exocrine ducts on the glycemia and histological structure of the pancreas]. C R Seances Soc Biol Fil. 1960;154:155–158. [PubMed]
  • LOUBATIERES A, SASSINE A, FRUTEAU DE LACLOS C, BOUYARD P. Actions des sulfamides hypoglycémiants sur la croissance du rat blanc et l'histologie du pancréas. C R Seances Soc Biol Fil. 1957;151(5):957–959. [PubMed]
  • LOUBATIERES A, SASSINE A, MARIANI MM, FRUTEAU DE LACLOS C. [Effects of the administration of sulfonamide by way of the exocrine ducts on the glycemia and histological structure of the pancreas]. C R Seances Soc Biol Fil. 1960;154:155–158. [PubMed]
  • DIENGOTT D, DOLGER H, MIRSKY IA. The relation of various variables to the hypoglycemic action of 1-butyl-3-p-tolylsulfonylurea in patients with diabetes mellitus. Metabolism. 1956 Nov;5(6 Pt 2):875–893. [PubMed]
  • MIRSKY IA, GITELSON S, PERISUTTI G. Inhibition of the diabetogenic action of somatotropin by tolbutamide. Ann N Y Acad Sci. 1959 Mar 30;74(3):499–512. [PubMed]
  • PFEIFFER EF, STEIGERWALD H, SANDRITTER W, BANDER A, MAGER A, BECKER U, RETIENE K. Vergleichende Untersuchungen von Morphologie und Hormongehalt des Kalberpankreas nach Sulfonylharnstoffen (D 860). Dtsch Med Wochenschr. 1957 Sep 6;82(36):1568–1574. [PubMed]
  • GOLDNER MG, LAZARUS SS, VOLK BW, WEISENFELD S. Mechanisms of action of the hypoglycemia-producing sulfonylurea derivatives, with some clinical observations. Metabolism. 1956 Nov;5(6 Pt 2):894–903. [PubMed]
  • YOUNG FG. Hypoglycaemic and anti-diabetic sulphonamides. Br Med J. 1956 Aug 25;2(4990):431–432. [PMC free article] [PubMed]
  • MEHNERT H, CAMERINI-DAVALOS R, MARBLE A. Results of long-term use of tolbutamide (orinase) in diabetes mellitus. J Am Med Assoc. 1958 Jun 14;167(7):818–827. [PubMed]
  • BROWN G, ZOIDIS J, SPRING M. Hepatic damage during chlorpropamide therapy. J Am Med Assoc. 1959 Aug 22;170(17):2085–2088. [PubMed]
  • DELAWTER DE, MOSS JM, TYROLER S, CANARY JJ. Secondary failure of response to tolbutamide treatment. J Am Med Assoc. 1959 Nov 28;171:1786–1792. [PubMed]
  • MURRAY I, RIDDELL MJ, WANG I. Chlorpropamide; a new hypoglycaemic agent. Lancet. 1958 Sep 13;2(7046):553–554. [PubMed]
  • STOWERS JM, CONSTABLE LW, HUNTER RB. A clinical and pharmacological comparison of chlorpropamide and other sulfonylureas. Ann N Y Acad Sci. 1959 Mar 30;74(3):689–695. [PubMed]
  • HALL GH, CROWLEY MF, BLOOM A. Oral treatment of diabetes; trail of phenethyldiguanide (D.B.I.). Br Med J. 1958 Jul 12;2(5088):71–74. [PMC free article] [PubMed]
  • POMERANZE J, MOURATOFF GT, GADEK RJ, KING EJ. Phenethylbiguanide, a new orally given hypoglycemic agent: report after two years of clinical experience. J Am Med Assoc. 1959 Sep 19;171:252–258. [PubMed]
  • STEINER DF, WILLIAMS RH. Actions of phenethylbiguanide and related compounds. Diabetes. 1959 Mar-Apr;8(2):154–157. [PubMed]
  • WALKER RS. Preliminary observations on phenethyldiguanide. Br Med J. 1959 Sep 12;2(5149):405–406. [PMC free article] [PubMed]
  • KRALL LP, WHITE P, BRADLEY RF. Clinical use of the biguanides and their role in stabilizing juvenile-type diabetes. Diabetes. 1958 Nov-Dec;7(6):468–477. [PubMed]
  • ODELL WD, TANNER DC, STEINER DF, WILLIAMS RH. Phenethyl-, amyl-, and isoamylbiguanide in the treatment of diabetes mellitus. AMA Arch Intern Med. 1958 Oct;102(4):520–526. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press